Search - tctmd.com

Displaying 281 - 300 of 2239

Sort: Relevancy | Date

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

October 25, 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

October 24, 2023

Patient-Level Meta-analysis on PTX Safety

Presentation TCT 2023

Patient-Level Meta-analysis on PTX Safety

Presenter: William Gray

October 24, 2023

Real World Evidence About PTX Safety

Presentation TCT 2023

Real World Evidence About PTX Safety

Presenter: Eric Secemsky

October 24, 2023

FDA Approves First Extravascular ICD

News Daily News

FDA Approves First Extravascular ICD

Yael L. Maxwell

October 23, 2023

A New Cardiovascular Board? A Few Things For Cardiology Leaders to Consider

News Opinion Off Script

A New Cardiovascular Board? A Few Things For Cardiology Leaders to Consider

Westby G. Fisher, MD

October 20, 2023

What’s Going to Be Hot at TCT 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

October 19, 2023

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

News Daily News

Rosuvastatin, Atorvastatin: Similar Efficacy in LODESTAR, Some Differing Signals

Yael L. Maxwell

October 19, 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

News Conference News HFSA 2023

ANTHEM-HFrEF Fails to Show Benefit of Vagal Nerve Stimulation Over GDMT

Yael L. Maxwell

October 16, 2023

Combined Surgical and Catheter Ablation Best for Persistent AF

News Conference News EACTS 2023

Combined Surgical and Catheter Ablation Best for Persistent AF

Michael O'Riordan

October 12, 2023

REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation

News Conference News HFSA 2023

REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation

October 11, 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

October 11, 2023

Similar Outcomes With Enteric-Coated and Uncoated Aspirin: ADAPTABLE

News Daily News

Similar Outcomes With Enteric-Coated and Uncoated Aspirin: ADAPTABLE

October 06, 2023

TCTMD’s Top 10 Most Popular Stories for September 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2023

October 03, 2023

Etripamil Continues to Show Promise in Paroxysmal SVT: NODE-302

News Daily News

Etripamil Continues to Show Promise in Paroxysmal SVT: NODE-302

September 27, 2023

Emulsifiers in Food Up CVD Risk and Should Be Avoided, Study Urges

News Daily News

Emulsifiers in Food Up CVD Risk and Should Be Avoided, Study Urges

Yael L. Maxwell

September 21, 2023

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

News Daily News

Real-world MitraClip Impact in Secondary MR: Reassuring for Some, Not All

Michael O'Riordan

September 18, 2023

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

News Daily News

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Michael O'Riordan

September 15, 2023

Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets

News Daily News

Evinacumab Helps Severe Hypercholesterolemia Patients Reach LDL Targets

Michael O'Riordan

September 14, 2023

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

September 12, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.